Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Rashmi Kumari

3 Pharma Stock Buys You Don’t Want to Miss

JNJ AZN NVO United States Pharmaceutical Steve Reitmeister AstraZeneca Plc Momentum Novo Nordisk AS

The pharmaceutical industry is expected to experience substantial growth in the coming years with expanding global medical needs. Also, the healthcare sector is relatively resilient during market downturns. Therefore, fundamentally strong pharma stocks Johnson & Johnson (JNJ), Novo Nordisk A/S (NVO), and AstraZeneca PLC (AZN) could be wise additions to your portfolio now.

According to U.S. pharmaceutical industry statistics, the U.S. will have a 43.72% market share in the global pharma industry in 2023. Also, the U.S. is expected to spend $605 to $635 billion on medicine by 2025.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Alice Zaslavsky’s shortcut beetroot baked risotto – recipe
An unconventional technique makes this vibrant rice – finished with dill fronds – a lower-touch dinner for weeknights
The Guardian - AU
The Guardian - AU
Does your sleep tracker get it right? A Pittsburgh neuroscientist weighs in
On a typical night, I go to bed wearing a tracking watch on one wrist and another type of tracker on the other wrist. Then I compare their sleep findings while I drink my morning coffee.
The Conversation
The Conversation
There's A Reason Taxi Cabs Are Almost Always Yellow
Yellow taxis are easy to spot in traffic, but the color's history goes far beyond simple visibility.
Motor1
Motor1
How ‘technoference’ can disrupt parent-child connections
Have you ever been telling someone a story when their phone lights up, and their eyes flicker toward their device?
The Conversation
The Conversation
Holding Lightning by Emily Lordi review – an intimate portrait of Whitney Houston
An empathetic biography of the the singer recasts her tumultuous later career as a triumph of self-expression
The Guardian - UK
The Guardian - UK
Brian May says Queen are retiring from live tours: ‘Maybe 50 years is enough’
Rock guitarist suggested creating an interactive experience for fans similar to the ‘Abba Voyage’ show
The Independent UK
The Independent UK
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play